Reason for request

Renewal of inclusion on the list of medicines refundable by National Health Insurance and Re-assessment of the actual benefit following the Transparency Committee conclusions in its opinions of 26 November 2008 and reiterated in its opinion of 21 September 2011.

-


Clinical Benefit

Insufficient

The actual benefit of PIASCLEDINE 300 mg capsules is in sufficient to justify reimbursement by National Insurance.


Contact Us

Évaluation des médicaments

See also